Stable plasma membrane expression of the soluble domain of the human insulin receptor in yeast  by Angermayr, Michaela et al.
Stable plasma membrane expression of the soluble domain of the human
insulin receptor in yeast
Michaela Angermayra, Gertrud Strobela, Gu«nter Mu«llerb, Wolfhard Bandlowa;*
aInstitut fu«r Genetik und Mikrobiologie, Maria-Ward-Strasse 1a, D-80638 Munich, Germany
bAventis Pharma Deutschland GmbH, Research Metabolic Diseases, Bldg. H825, D-65926 Frankfurt, Germany
Received 13 July 2000; accepted 8 August 2000
Edited by Horst Feldmann
Abstract The soluble cytoplasmic kinase domain of the human
insulin receptor was N-terminally equipped with either an
N-acetylation or a dual-acylation motif (MGC box, to allow
myristoylation/palmitoylation) and expressed in yeast cells under
the control of the inducible CUP1 promoter. Although the
cellular concentration was about the same in both instances
(reflecting similar stability against proteolysis), only the
myristoylated protein was capable of autophosphorylation to a
significant extent and was active to phosphorylate endogenous
yeast proteins at tyrosine residues in vivo. Cellular subfractiona-
tion showed that the insulin receptor was associated with plasma
membranes, from where it was not extractable with high salt or
alkali, but a significant fraction was also localized in the nuclear
fraction. The myristoylated protein is absent from the cytoplasm.
No effect of expression of either the acetylated or the
myristoylated version on growth and respiration on various
carbon sources was detected, suggesting a failure of the active
insulin receptor kinase domain to couple to yeast (glucose)
signalling cascades. ß 2000 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Glycogen metabolism in yeast ^ as in vertebrates ^ is con-
trolled by nutrients, e.g. glucose, at the transcriptional level
and, in addition, via a phosphorylation/dephosphorylation
mechanism of the two key enzymes, glycogen synthetase
(Gsy2p) and glycogen phosphorylase [1^4]. In the presence
of glucose, Gsy2p is inhibited by phosphorylation on three
serine residues in the C-terminal domain and, conversely,
phosphorylase is activated by phosphorylation [5,6]. Previ-
ously, we have described that in yeast under conditions of
growth limitation, these glucose-dependent e¡ects are signi¢-
cantly enhanced by the simultaneous presence of human in-
sulin (hIns) at concentrations 10^100-fold above those e¡ec-
tive in mammalian insulin-responsive cells [6^8]. In addition,
the glucose e¡ect on several other enzymes (cAMP-dependent
protein kinase A and cAMP phosphodiesterase, protein phos-
phatase 2A and glycosylphosphatidylinositol-speci¢c phos-
pholipase C) was enhanced analogously by hIns [6,8], strictly
in the same fashion as in vertebrate insulin-responsive cells [9^
11]. The regulatory responses correlated well with the speci¢c
hIns binding to a 53 kDa yeast plasma membrane protein (to
which it could be cross-linked chemically), and with its ligand-
dependent Ser/Thr phosphorylation. We did not observe any
responses or binding to the membrane protein of growth fac-
tors closely related to insulin, such as insulin-like or epidermal
growth factors, or of certain point mutations of hIns [12,13].
Together, these observations suggest that yeast harbors some
components of an evolutionarily conserved mechanism which
induces the multitude of intracellular processes in response to
the presence of glucose that are subsumed under the term
‘glucose repression’ via an insulin-related signalling molecule.
The genes encoding the presumptive ligand and receptor
have not yet been uncovered by the yeast genome sequencing
project. From this failure and from the striking di¡erence in
molecular mass and phosphorylation behavior to vertebrate
insulin receptors it is evident that, if yeast has an insulin
recognizing protein, its primary structure is poorly conserved.
We examined whether the soluble cytoplasmic domain of the
L-chain of hIns receptor (hInsR), which has been demon-
strated to exhibit similar catalytic properties and to use the
identical sites in autophosphorylation as the native holo-re-
ceptor [14^18], could couple to intracellular components of
the yeast glucose signalling cascade. We reasoned that these
downstream constituents might be conserved in evolution to a
higher degree than the putative insulin-like ligand and its re-
ceptor. We expressed hInsR in yeast cells in enzymatically
active and plasma membrane-associated form and analyzed
its e¡ects.
2. Materials and methods
2.1. Cloning and expression of hInsR in yeast cells
The complete cytoplasmic domain of the L-subunit of hInsR (amino
acid positions 940^1355 of the short version [19,20]) was ampli¢ed
from a cDNA clone using forward primers which additionally
contained an N-acetylation motif (amino acid sequence: MSSSTT)
(InsRAc: 5P-CTAGTATAATGTCTTCATCTACTAGATCTAATG-
CTAGCAACCTGAGAAAGAGGCAGCCAG-3P) or an N-myristoyl-
ation site (amino acid sequence: MGCTVSSQTT) (InsRMy: 5P-
CTAGTATAATGGGTTGTACTGTATCTTCCCAAACTAGATCT-
AATGCTAGCAACCTGAGAAAGAGGCAGCCAG-3P). The re-
verse primer was InsRrev: 5P-CATGGTTAGGAAGGATTGGAC-
CG-3P. The two ampli¢cates were each ligated to the SpeI and NcoI
sites of pEX [21]. The CUP1 promoter was inserted into the respective
BamHI and SpeI sites of pEX as a BamHI/NheI fragment [22]. Pro-
moter, InsR coding sequence and terminator were recloned as a Bam-
HI/HindIII fragment in either the 2W-based vector YEp352 [23] or the
ARS/CEN vector pFL38 [24]. Yeast (strain CEN.PK2-1C MATa [25])
transformed with one of these or a control plasmid (YEp352 or
pFL38) was grown on 3% YPD medium overnight and induced
with 1 mM CuSO4 for 4 h.
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2.2. Cellular subfractionation
Yeast spheroplasts (from 4 l yeast culture, titer 2U107) were broken
by shearing and osmotic lysis (0‡C) in 0.6 M mannitol bu¡er contain-
ing a mixture of protease and phosphatase inhibitors (1 mM phenyl-
methylsulfonyl £uoride, 0.6 Wg/ml pepstatin, 0.25 U/ml aprotinin,
10 mM sodium £uoride, 1 mM Na vanadate). The supernatant of a
low speed pellet (5 min, 1500Ug) was centrifuged (10 min, 20 000Ug)
to obtain crude mitochondria and nuclei. This supernatant was then
centrifuged (Beckman TLA-100.4 rotor, 45 min, 120 000Ug) to yield a
particulate fraction, which was essentially free of mitochondria and
nuclei and mainly contained plasma membranes, and a non-particu-
late cytoplasmic supernatant fraction. Crude mitochondria and nuclei
were separated by centrifugation (30 min, 38 000Ug) in a 28% Percoll
(Pharmacia, Freiburg) gradient [26]. All fractions were separated by
SDS^PAGE (10%), electroblotted onto Immobilon P membrane
(Millipore, Eschborn) and immunodecorated. Polyclonal anti-InsR
(Santa Cruz, Heidelberg) and a mixture of anti-P-Tyr antisera (rabbit,
purchased from Transduction Laboratories, Lexington, KY, and
monoclonal PY99 from mouse, Santa Cruz, Heidelberg) or anti-pep-
tide antibodies (goat, obtained from Santa Cruz, Heidelberg) directed
against the marker proteins Rap1p (nuclei), Cyr1p (Cdc35p, plasma
membranes and cytoplasm) or Cdc24p (plasma membranes) were
used.
2.3. Miscellaneous procedures
Cell extracts used in Western blot analysis were prepared from 5 ml
of a culture of logarithmically growing cells. The cell sediment plus
120 Wl breakage bu¡er (20 mM Tris^HCl, pH 7.4, 2% SDS, 30 mM
L-mercaptoethanol) plus 150 Wl glass beads (0.45 mm in diameter) was
boiled for 2 min and then homogenized on a Vortex for a total period
of 2 min. The supernatant was directly used for SDS^PAGE. Extrac-
tions of subcellular fractions (100 Wg of protein each) with high salt
(1 M NaCl) or alkali (0.2 M Na2CO3, pH 10.5) was performed as
previously described [27]. The soluble supernatant fraction and the
pellet were analyzed separately by SDS^PAGE. Tyrosine-speci¢c re-
combinant YOP phosphatase (from Yersinia enterocolitica) was pur-
chased from New England Biolabs, Frankfurt. Phosphotyrosine was
dephosphorylated as recommended by the manufacturer. Cells were
broken with glass beads (10 pulses of 30 s each interrupted by cooling
on ice, microscopic monitoring of breakage e⁄ciency) in the presence
of a protease inhibitor mix (end concentrations: 0. 25 U/ml aprotinin,
1 mM phenylmethylsulfonyl £uoride, 1.8 Wg/ml pepstatin, 1.8 Wg/ml
leupeptin), and in the simultaneous presence or absence of 50 U YOP
and/or phosphatase inhibitors (end concentrations: 1 mM (in the
presence of YOP, 10 mM) NaVO3, 10 mM NaF, 10 mM inorganic
pyrophosphate, 10 mM K-glycerophosphate). The reactions were ter-
minated by boiling in SDS bu¡er at the time points indicated and
50 Wg protein per lane was separated by SDS^PAGE (10% gels) and
immunodecorated. Protein determinations [28] and molecular proce-
dures [29] have been described.
3. Results
The CUP1 promoter was used for regulated expression of
the human insulin receptor (hInsR) in yeast cells as its induc-
tion does not interfere with nutritional signalling (in contrast
to the GAL1/10 or the PHO5 promoters). Expression from
multi-copy plasmids of the two hInsR constructs was induced
3^10-fold by CuSO4 (Fig. 1A). The cellular concentrations of
the two di¡erent N-terminally modi¢ed versions were compa-
rable. The electrophoretic mobilities of the recombinant pro-
teins in SDS^PAGE corresponded to molecular masses of
about 48 kDa. No degradation products were observed (in
contrast to expression in Escherichia coli, not shown). In yeast
strains defective for the proteasome subunits Pre1p and Pre2p
[30] or for the vacuolar proteinases A and B and carboxypep-
tidases Y and S [31], the electrophoretic mobility was un-
changed (not shown) indicating that the hInsR protein was
proteolytically stable in vivo in the genetic background of the
protease-pro¢cient wild-type.
In order to protect the heterologous protein against possible
proteolytic degradation in vivo the two constructs had been
equipped either with an N-acetylation sequence (deduced from
the N-terminus of N-acetylated major adenylate kinase [32]),
hInsRAc, or with an MGC box motif, MGCTVSS, hInsRMy,
which was derived as a consensus from hSrc and the two yeast
proteins, Gpa1p (which has been shown to be N-myristoylated
in vivo [33]) and Gpa2p. In addition to mere protection from
proteolysis, myristoylation of the N-terminal Gly in the ma-
ture protein and possible palmitoyl thioesteri¢cation of the
neighboring cysteine residue was intended to allow association
with the inner face of the plasma membrane. This was meant
to mimic the topological situation in vertebrate cells. In mam-
malian insulin-responsive cells, insulin binding to the mem-
brane-expressed dimeric receptor triggers a close juxtaposi-
tioning of the two L-chains of the holo-receptor to induce
trans-chain autophosphorylation of the cytoplasmic domains
[34,35]. In order to facilitate these bimolecular interactions
within the insulin receptor and between the receptor and pu-
tative substrate proteins in yeast, the receptor construct com-
prised the complete juxtamembrane domain equipped with a
membrane anchor in addition to the kinase and the C-termi-
nal regulatory domains.
To examine whether the heterologously expressed InsR pro-
tein fragment exhibited enzymatic activity and was autophos-
phorylated in yeast, the same samples from glucose-grown
cells were electrophoretically separated as in Fig. 1A but dec-
orated with a mixture of polyclonal anti-P-Tyr antiserum and
monoclonal PY99. A number of tyrosine-phosphorylated
yeast proteins were detected in the transformant expressing
Fig. 1. Heterologous expression and tyrosine phosphorylation of the
soluble domain of the human insulin receptor, hInsR. A: Induction
of expression. Cells of the transformant strains harboring hInsRAc,
hInsRMy or YEp352 (control) were grown in the absence or pres-
ence of 1 mM CuSO4 (as indicated) for 4 h. The proteins were sep-
arated by SDS^PAGE, transferred to Immobilon P membrane and
immunodecorated with a polyclonal anti-hInsR antiserum. B: Test
for autophosphorylation of hInsR on tyrosine residues. The same
protein preparations of transformant strains were used as in A and
the Western blot decorated with a mixture of polyclonal anti-tyro-
sine phosphate antiserum and a monoclonal anti-P-Tyr antibody.
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hInsRMy (Fig. 1B, lanes 3 and 4) whereas tyrosine phosphor-
ylation was poorly to not detectable with the N-acetylated
protein (lanes 1 and 2), although the cellular concentrations
of the two versions of hInsR had been comparable (see Fig.
1A). One of the major signals in lanes 3 and 4 (corresponding
to the lower band of the doublet indicated at the margin of
the ¢gure) coincided with hInsRMy showing that the protein
was autophosphorylated. In addition, several signals of Tyr
phosphorylation, corresponding to polypeptides, both larger
and smaller than InsR, were found. Degradation of hInsRMy
and unspeci¢c cross-reactivity with non-phosphorylated pro-
teins could be excluded by comparison with the polyclonal
anti-hInsR antiserum or with the vector control, YEp352,
respectively. Consequently these signals represent tyrosine-
phosphorylated yeast proteins. Furthermore, phosphorylation
of yeast proteins relied on the presence of autophosphorylated
hInsRMy as it was absent from the controls (YEp352 vector,
lanes 5 and 6 and from hInsRAc, lanes 1 and 2). The degree
of Tyr phosphorylation of yeast proteins correlated with the
strength of hInsRMy expression (compare non-induced and
induced expression of hInsMy in lanes 3 and 4 of Fig. 1A,B).
Similar signals were found after growth of cells on non-fer-
mentable carbon sources (not shown).
To substantiate further that hInsRMy was phosphorylated
on tyrosine residues, cells were broken after induction and
proteins exposed to either endogenous phosphatases for in-
creasing periods of time or to recombinant YOP tyrosine-spe-
ci¢c protein phosphatase from Y. enterocolitica. As a control,
cells were broken and incubated in the presence of a phospha-
tase inhibitor mix (vanadate, £uoride, K-glycerophosphate,
inorganic pyrophosphate) which inhibits protein tyrosine
phosphatases. Cell homogenates decorated with anti-hInsR
antibody (Fig. 2A) served as the loading control. The phos-
phate residues were rapidly removed by added tyrosine phos-
phatase (YOP) (Fig. 2B, lane 10) as well as by endogenous
yeast tyrosine phosphatases (lanes 1^4) as evident from the
disappearance of the signal after incubation with the mixture
of anti-P-Tyr-speci¢c antisera. On the other hand, phospho-
tyrosine was protected to a signi¢cant extent by the inhibitor
mix (lanes 5^8) which is particularly signi¢cant in the case of
simultaneous presence of YOP and inhibitors (lane 9) to dem-
onstrate P-Tyr speci¢city of YOP and its inhibition by the
mix.
The ¢nding that hInsRMy was autophosphorylated and
able to phosphorylate yeast proteins on Tyr residues, whereas
hInsRAc was not, is most plausibly explained by the assump-
tion that hInsRMy associated with the plasma membrane and
hInsRAc was cytoplasmic. To test this issue, cells were sub-
fractionated as described in Section 2 (mitochondria and nu-
clei further puri¢ed by gradient centrifugation) and the frac-
tions analyzed by Western blotting (Fig. 3). Sera directed
against compartment-speci¢c marker proteins were used to
prove absence of mutual contaminations. Purity of nuclei
was challenged by a serum against the general transcription
factor, Rap1p, in Fig. 3C; anti-adenylate cyclase (Cdc35p)
was speci¢c for plasma membranes and cytoplasm in Fig.
Fig. 2. Treatment with protein tyrosine phosphatase. Proteins from
the hInsRMy-containing transformant strain were prepared in the
presence of a mix of protease inhibitors with or without additional
protein tyrosine phosphatase inhibitors (PP-I) or P-Tyr phosphatase
(YOP) as indicated. 40 Wg of protein was incubated at room tem-
perature in the absence or presence of YOP P-tyrosine phosphatase
(50 U) for the periods indicated t (min), separated by SDS^PAGE
and immunodecorated with antisera directed against hInsR (A) or
P-Tyr (B).
Fig. 3. Subfractionation of hInsRAc and hInsRMy transformant
cells. Nuclei (N), plasma membranes (M) and soluble cytoplasmic
fraction (C) from hInsRMy- or hInsRAc-expressing transformants
were separated by SDS^PAGE and identi¢ed by Western blotting.
Immunodecoration with anti-hInsR antiserum (A), anti-P-Tyr (B),
anti-peptide antibodies directed against speci¢c marker proteins,
Rap1p (nuclei, C), Cdc35p (plasma membranes and cytoplasm, D),
or Cdc24p (plasma membranes, E).
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3D, and anti-Cdc24p detected a protein present in plasma
membranes in Fig. 3E. The vast majority of hInsRMy was
found in the fraction containing nuclei, a smaller portion in
plasma membranes, whereas the soluble supernatant (and mi-
tochondria, not shown) did not contain detectable amounts of
the protein (Fig. 3A). Surprisingly, it turned out that hInsRAc
was only partly cytoplasmic. The majority of this protein also
occurred in nuclei and about equal amounts were found in the
plasma membrane fraction and in the cytoplasm. Mitochon-
dria (not shown) were de¢nitely devoid of the protein.
hInsRMy was autophosphorylated, when associated with ei-
ther plasma membranes or nuclei. Also Tyr-phosphorylated
yeast proteins could be found in these two fractions, whereas
only a very few minor substrate proteins were detected by the
anti-P-Tyr antiserum in the cytoplasmic fraction (Fig. 3B).
hInsRAc failed to autophosphorylate or to phosphorylate
other proteins.
To determine the nature of the membrane association of the
two versions of the hInsR protein, plasma membranes and
nuclei were extracted with high salt or alkali [27]. No material
of hInsRMy and only a minor fraction of hInsRAc could be
extracted under either condition (Fig. 4A,B). Accordingly,
neither of the proteins was loosely attached to the respective
membrane, but rather behaved as a membrane protein. This
was unexpected for hInsRAc and suggested that it was either
inserted into the membrane by a lipophilic stretch of amino
acids or, since this was not apparent from the primary struc-
ture, more likely, by rather stable protein^protein interac-
tions.
The above results demonstrate that the prerequisites for a
functional coupling of the heterologously expressed hInsR to
putative downstream glucose signalling components of yeast
were ful¢lled: hInsRMy was located at the plasma membrane
and in the nucleus and was constitutively autophosphorylated
and capable of phosphorylating endogenous target proteins
on Tyr residues. We tested functional coupling in yeast and
examined whether the expression of active hInsR had any
physiological consequences by measuring growth rates, respi-
ration and glycogen accumulation on various carbon sources.
We did not detect any signi¢cant di¡erences to the wild-type
transformed with a control plasmid on either glucose or non-
fermentable carbon sources. In addition, iodine vapor staining
revealed no di¡erences between wild-type and transformant
indicating that deposition of glycogen was about the same
in the two strains (data not shown). This suggested that the
heterologous protein did not interfere with the intrinsic yeast
system of glucose signalling. This ¢nding was in line with the
observation that the pattern of Tyr-phosphorylated target
proteins was not in£uenced by the carbon source (see above).
4. Discussion
The soluble cytoplasmic protein tyrosine kinase domain of
hInsR has previously been expressed in the baculovirus ex-
pression system (Sf9 insect cells) in active form. These studies
were undertaken in order to identify autophosphorylated ty-
rosine and serine/threonine residues [18,36] in InsR (in the
absence of insulin) and analyze their importance in tyrosine
kinase activity and signal transduction [14^17,37]. Here, we
describe the stable expression of the complete cytoplasmic
protein fragment of hInsR including the juxtamembrane do-
main in yeast cells. The protein has an apparent molecular
mass of 48 kDa. In addition, we show that this protein is
capable of autophosphorylation. Cross-reactivity of the 48
kDa protein with the anti-InsR and either of the two anti-
P-Tyr antisera as well as the rapid removal of these signals by
YOP protein phosphotyrosine phosphatase proves that
hInsRMy is autophosphorylated on tyrosine residues after
heterologous expression in yeast cells. Furthermore, several
endogenous yeast proteins are phosphorylated on tyrosine
residues in a hInsR-dependent way. The degree of autophos-
phorylation correlates well with the e⁄ciency of tyrosine
phosphorylation of these intrinsic substrates corroborating
that the protein tyrosine kinase activity of hInsR is stimulated
by autophosphorylation as in the insect system.
The protein tyrosine kinase domain was N-terminally fused
to either an N-acetylation signal as a protein stabilizing se-
quence or an MGC box to allow membrane attachment
through N-terminal lipophilic modi¢cation by myristate and,
presumably, palmitate as has been veri¢ed in yeast in the case
of Gpa1p, the GK subunit of the trimeric G protein in the
pheromone response pathway [33]. N-terminal membrane an-
chorage of the hInsRMy construct was veri¢ed by cellular
subfractionation and shown to greatly enhance autophosphor-
ylation in vivo. Most plausibly, this is due to the reduction of
degrees of freedom and velocity of protein di¡usion leading to
an increased probability of bimolecular interaction to allow
autophosphorylation. In contrast, hInsRAc is not autophos-
phorylated, although a large fraction of hInsRAc also co-pu-
ri¢ed with plasma membranes and was not extracted by high
salt or alkali. This behavior cannot be explained at present.
The occurrence of hInsR in yeast nuclei was unexpected.
Interestingly, a fraction of ligand-bound insulin receptor has
been reported to co-fractionate with nuclei from mammalian
insulin-responsive cells [38]. Furthermore, microinjection of
human insulin into nuclei of Xenopus oocytes has been dem-
onstrated to elicit mitogenic e¡ects, such as stimulation of
DNA synthesis [39]. These observations imply a functional
role of insulin receptors in the nucleus possibly exerted after
receptor activation in response to insulin binding and endo-
cytotic tra⁄cking. Conversely, these observations from verte-
brates imply that the recombinant cytoplasmic domain of the
receptor is committed and su⁄cient for nuclear import in
Fig. 4. Extraction of nuclei and plasma membranes of transformant
cells of hInsRMy and hInsRAc with high salt (A) or alkali (B). Nu-
clei (N) or plasma membranes (M) (100 Wg of protein each) were
extracted with either 1 M NaCl or 0.2 M Na2CO3, pH 10.5 [27],
and soluble extracts (S) or pellet (P) proteins were electrophoresed
and immunodecorated as above using an anti-hInsR antiserum.
C indicates the non-extracted control fraction.
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yeast despite the absence of a transmembrane domain and the
uncoupling from an extracellular signal.
Surprisingly, tyrosine phosphorylation of intrinsic proteins
had no apparent impact on the physiology of the yeast cells
measured as growth rate on glucose or non-fermentable car-
bon sources or on respiratory rates or glycogen accumulation.
This suggested that the constitutive tyrosine kinase activity of
the hInsR did not interfere with glucose signalling in yeast.
The failure to detect signi¢cant physiological consequences of
the expression of the constitutively active tyrosine kinase do-
main of hInsR in yeast could be due to (i) too low kinase
activity, (ii) rapid dephosphorylation and thereby inactivation
of the kinase or (iii) absence of a homologue of the major
substrate proteins, IRS-1^4, from yeast, which mediates most
responses to insulin in mammals [40]. The assay of intrinsic
Tyr-phosphatases argues that Tyr-phosphorylated proteins
are only gradually dephosphorylated in a yeast cell homoge-
nate. It must be deduced that the yeast target proteins of
hInsR play no role in glucose signalling in yeast. This makes
explanation iii the most likely and argues that the kinase
activity of hInsR fails to activate the major substrate poly-
peptide(s) of the putative yeast InsR. Such a protein domain
fused to the receptor has been detected in the nematode Cae-
norhabditis elegans, which has been shown to harbor a com-
plete insulin-like signalling cascade ([41], reviewed in [42]).
Likely, in lower eukaryotes such as C. elegans and Saccharo-
myces cerevisiae the endogenous InsR/insulin receptor sub-
strate-like molecules directly feed into the downstream devel-
opmental or glucose signalling pathways, respectively. In
yeast, the downstream components can be activated by exog-
enous mammalian insulin [8,42] but apparently fail to interact
with the hInsR. Possibly, co-expression of the kinase domain
of hInsR and IRS-1 is required for functional coupling of the
former to the glucose signalling cascade in yeast.
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